Search - tctmd.com

Displaying 841 - 860 of 1622

Sort: Relevancy | Date

Presentation TCT 2017

Why I Use Cangrelor for Primary PCI in STEMI!

Presenter: Michael S. Lee, Dirk Sibbing, Dmitriy N. Feldman

October 30, 2017

Presentation TCT 2017

Why I Prefer Bivalirudin for Primary PCI in STEMI!

Presenter: Michael S. Lee, Dirk Sibbing, Uwe Zeymer

October 30, 2017

Presentation TCT 2017

STEMI With Cardiogenic Shock and Cardiac Arrest: What Do the US Guidelines and AUC Say?

Presenter: Sripal Bangalore, Manesh R. Patel, Gregory J. Dehmer

October 30, 2017

Presentation TCT 2017

Why I Prefer a Heparin Plus a GPI for Primary PCI in STEMI!

Presenter: Michael S. Lee, Dirk Sibbing, Eric R. Bates

October 30, 2017

$Why I Prefer Unfractionated Heparin Without GPI for Primary PCI in STEMI!$

Presentation TCT 2017

Why I Prefer Unfractionated Heparin Without GPI for Primary PCI in STEMI!

Presenter: Michael S. Lee, Dirk Sibbing, A. Michael Lincoff

October 30, 2017

Presentation TCT 2017

STEMI With Cardiogenic Shock and Cardiac Arrest: What Do the Data and EU Guidelines Say?

Presenter: Sripal Bangalore, Manesh R. Patel, Holger Thiele

October 30, 2017

Presentation TCT 2017

Case Introduction: A Patient With STEMI, Cardiogenic Shock, and Cardiac Arrest How Should We Treat?

Presenter: Sripal Bangalore, Manesh R. Patel, Navin K. Kapur

October 30, 2017

Presentation TCT 2017

STEMI Case Presentation: Why the Choice of Patental Therapy Matters

Presenter: Michael S. Lee, Dirk Sibbing, Francesco Franchi

October 30, 2017

Presentation TCT 2017

Case Resolution: STEMI With Multivessel Disease How We Treated

Presenter: Sripal Bangalore, Anthony H. Gershlick, Prashant Kaul

October 30, 2017

Presentation TCT 2017

STEMI/ACS With Multivessel Disease: What Do the US Guidelines and AUC Say?

Presenter: Sripal Bangalore, Anthony H. Gershlick, Jacqueline E. Tamis-Holland

October 30, 2017

Presentation TCT 2017

STEMI/ACS With Multivessel Disease: What Do the Data and EU Guidelines Say?

Presenter: Sripal Bangalore, Anthony H. Gershlick, Stefan K. James

October 30, 2017

Presentation TCT 2017

Case Introduction: STEMI With Multivessel Disease How Should We Treat?

Presenter: Sripal Bangalore, Anthony H. Gershlick, Prashant Kaul

October 30, 2017

Presentation TCT 2017

In This Case: iFR/FFR in Assessment of ACS Culprit and Nonculprit Stenoses (With Discussion)

Presenter: Justin E. Davies, Nils Johnson, Matthias Götberg

October 30, 2017

Presentation TCT 2017

Case #3: STEMI and Multivessel Disease (With Discussion)

Presenter: Timothy D. Henry, Thomas D. Stuckey, Dariusz Dudek

October 30, 2017

News Conference News TCT 2017

Live From Denver: TCT 2017, Day One

Shelley Wood

October 30, 2017

Presentation TCT 2017

Case #2: Massive Thrombus in STEMI - Beyond Aspiration, Enter Creativity (With Discussion)

Presenter: Timothy D. Henry, Thomas D. Stuckey, David A. Cox

October 30, 2017

News Conference News TCT 2017

No Late Quality of Life Trade-offs With PCI in Left Main Disease: EXCEL-QOL Substudy

Michael O'Riordan

October 30, 2017

News Conference News TCT 2017

CULPRIT-SHOCK Disputes Benefit of Immediate Multivessel PCI in Patients With Cardiogenic Shock

Todd Neale

October 30, 2017

News Conference News TCT 2017

Help for Clinicians Whose Patients Need to Switch P2Y12 Inhibitors

Todd Neale

October 30, 2017

Presentation TCT 2017

Predicting the Future: Will the Ongoing COMPLETE Trial Change the Current Recommended Approach to Multivessel Disease in STEMI?

Presenter: C. Michael Gibson, Stephan Windecker, David Hildick-Smith

October 30, 2017

Advertisement

Why I Use Cangrelor for Primary PCI in STEMI!

Why I Prefer Bivalirudin for Primary PCI in STEMI!

STEMI With Cardiogenic Shock and Cardiac Arrest: What Do the US Guidelines and AUC Say?

Why I Prefer a Heparin Plus a GPI for Primary PCI in STEMI!

Why I Prefer Unfractionated Heparin Without GPI for Primary PCI in STEMI!

STEMI With Cardiogenic Shock and Cardiac Arrest: What Do the Data and EU Guidelines Say?

Case Introduction: A Patient With STEMI, Cardiogenic Shock, and Cardiac Arrest How Should We Treat?

STEMI Case Presentation: Why the Choice of Patental Therapy Matters

Case Resolution: STEMI With Multivessel Disease How We Treated

STEMI/ACS With Multivessel Disease: What Do the US Guidelines and AUC Say?

STEMI/ACS With Multivessel Disease: What Do the Data and EU Guidelines Say?

Case Introduction: STEMI With Multivessel Disease How Should We Treat?

In This Case: iFR/FFR in Assessment of ACS Culprit and Nonculprit Stenoses (With Discussion)

Case #3: STEMI and Multivessel Disease (With Discussion)

Live From Denver: TCT 2017, Day One

Case #2: Massive Thrombus in STEMI - Beyond Aspiration, Enter Creativity (With Discussion)

No Late Quality of Life Trade-offs With PCI in Left Main Disease: EXCEL-QOL Substudy

CULPRIT-SHOCK Disputes Benefit of Immediate Multivessel PCI in Patients With Cardiogenic Shock

Help for Clinicians Whose Patients Need to Switch P2Y12 Inhibitors

Predicting the Future: Will the Ongoing COMPLETE Trial Change the Current Recommended Approach to Multivessel Disease in STEMI?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content